15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Nyxoah, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $3.00 to $6.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $5.00 sits 210% above the current $1.61. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.15 next quarter toward $-0.73 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Nyxoah.
As of Sep, 2 of 3 firms rate NYXH a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NYXH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.15
Range $-0.20 – $-0.04 · 4 analysts · -74% YoY
Next period, 4 analysts expect Nyxoah to earn $-0.15 a share (range $-0.20 – $-0.04), versus $-0.59 a year earlier. Full-year consensus is $-1.26, growing to $-0.73 the year after.
REVENUE · NEXT QUARTER
$13.6M
Range $13.2M – $14.2M · 4 analysts · +141% YoY
Revenue is expected to reach $13.6M (range $13.2M – $14.2M), +141.3% year-over-year. Full-year consensus is $37.7M, rising to $72.8M next year.
Top analysts covering Nyxoah
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NYXH.
#1
Jonathan Block
Stifel · Rank #205
Hold
$3.00+85.8% to target
Overall win rate
41%
+ Follow
#2
Sarah James
Cantor Fitzgerald
Buy
$6.00+271.5% to target
Coverage
—
+ Follow
#3
Adam Maeder
Piper Sandler
Buy
$6.00+271.5% to target
Coverage
—
+ Follow
#4
MP
Michael Polark
Wolfe Research
Hold
No targeton NYXH
Coverage
—
+ Follow
#5
DR
David Rescott
Baird
Hold
$4.62+186.1% to target
Coverage
—
+ Follow
NYXH stock forecast FAQ
What is NYXH's average 12-month price target?+
The 3 analysts with a live target average $5.00 for Nyxoah over the next 12 months, ranging from a $6.00 high to a $3.00 low.
Is NYXH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NYXH?+
The Street-high target is $6.00 (Cantor Fitzgerald), and the Street-low is $3.00 (Stifel). The average of all 3 active targets is $5.00.
How many Wall Street analysts cover NYXH?+
3 analysts have an active rating on Nyxoah, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering NYXH?+
Among analysts who currently cover NYXH, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #205). Their current call is Hold with a $3.00 target.
What is Nyxoah's projected EPS for next quarter?+
The consensus estimate is $-0.15 per share (range $-0.20 – $-0.04) across 4 analysts. Full-year EPS is projected at $-1.26, rising to $-0.73 the following year.
How much revenue is Nyxoah expected to report next quarter?+
Consensus revenue is $13.6M (range $13.2M – $14.2M). Full-year revenue is projected at $37.7M, growing to $72.8M next year.
Have analysts been upgrading or downgrading NYXH lately?+
As of Sep, 2 of 3 firms rate NYXH a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NYXH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.